ACTRN12612000527864
Not yet recruiting
Phase 2
Men diagnosed with early stage prostate cancer and prescribed radiation therapy with or without neo-adjuvant androgen deprivation therapy will receive a specifically designed continence promotion intervention including a tailored pelvic floor muscle exercise program aimed at reducing lower urinary tract , lower bowel symptoms and erectile dysfunction
niversity of Newcastle0 sites40 target enrollmentMay 18, 2012
ConditionsProstate Cancer TreatmentLower Urinary Tract sequelae to radiation therapy with or without androgen deprivation therapyLower Bowel Dysfunction as sequelae to radiation therapy with or without androgen deprivation therapyErectile Dysfunction as sequelae to radiation therapy with or without androgen deprivation therapyCancer - ProstatePhysical Medicine / Rehabilitation - PhysiotherapyRenal and Urogenital - Other renal and urogenital disorders
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Prostate Cancer Treatment
- Sponsor
- niversity of Newcastle
- Enrollment
- 40
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Early stage prostate cancer
Exclusion Criteria
- •Not fluent in English
- •Neurological conditions
- •Other bladder conditions
- •Secondary malignancies
- •Profoundly Deaf
- •Legally blind
- •Abdominal surgery in past 2 years
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
PROCOG: Investigating Cognitive Problems in Men with Prostate CancerProstate CancerCognitive problemsCancer - ProstateMental Health - Studies of normal psychology, cognitive function and behaviourMental Health - AnxietyMental Health - DepressionMental Health - Other mental health disordersACTRN12621001608853Macquarie University150
Recruiting
Not Applicable
The safety and efficacy of Irreversible Electroporation for the ablation of prostate cancer assessed by procedural related side effects and post prostatectomy histology: A pilot studyProstate cancerCancer - ProstateACTRN12612000523808Flack Trustees6
Completed
Phase 1
Radionuclide therapy using Lutetium-177 prostate specific membrane antigen (PSMA): a pilot study in men with castrate-resistant prostate cancer (LuPSMA trial)Prostate CancerCancer - ProstateACTRN12615000912583Peter MacCallum Cancer Centre30
Recruiting
Not Applicable
Detection of clinically significant prostate cancer with MRI-TRUS fusion image-guided biopsy: comparison of the evaluation system (PI-RADS category vs. PI-RADS + US evalutaion)Suspected prostate cancerJPRN-UMIN000050631Tokai University80
Recruiting
Not Applicable
Prostate cancer background, QOL, patient's satisfaction and treatment survey by Japan Prostate Cancer Study GroupProstate cancerJPRN-UMIN000004666J-CaP study group10,000